17 research outputs found

    Additional file 1 of Subsidized gestational diabetes mellitus screening and management program in rural China: a pragmatic multicenter, randomized controlled trial

    No full text
    Additional file1: Fig. S1. Study sites. Fig. S2. Flowchart. Fig. S3. Fasting blood glucose values (mmol/L) in women diagnosed with GDM between the intervention group and control group (two-week interval). Fig. S4. The 2h-postprandial blood glucose (mmol/L) in women diagnosed with GDM between the intervention group and control group (two-week interval). Table. S1. Maternal and neonatal complications related to GDM. Table. S2. Baseline characteristics of pregnant women of included participants and those lost to follow-up. Table. S3. Effects of subsidy (intervention) on maternal and neonatal outcomes for overall women and GDM women. Table. S4. Effects of subsidy (intervention) on five common complications in pregnant women and newborns. Table. S5. Other complications (besides five common complications) in pregnant women and newborn. Table. S6. Maternal and neonatal complications between the intervention group and the control group adjusted by province. CONSORT guidelines CONSORT 2010 checklist of information to include when reporting a randomized trial. Supporting Material The protocol of lifestyle management for intervention group

    Additional file 3: of Sexual dysfunction and mode of delivery in Chinese primiparous women: a systematic review and meta-analysis

    No full text
    The results of the included studies through sensitivity analysis. Figure S1. Sensitivity analysis of 5 studies with the random effects model for sexual satisfaction within 3 months after delivery. Figure S2. Sensitivity analysis of 6 studies with the fixed effects model for sexual satisfaction within 6 months after delivery. Figure S3. Sensitivity analysis of 9 studies with the random effects model for resumed intercourse within 3 months after delivery. Figure S4. Sensitivity analysis of 8 studies with the fixed effects model for resumed intercourse within 6 months after delivery. Figure S5. Sensitivity analysis of 7 studies with the fixed effects model for sexual pain within 3 months after delivery. Figure S6. Sensitivity analysis of 7 studies with the fixed effects model for sexual pain within 6 months after delivery. (DOCX 957 kb

    Additional file 1 of Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study

    No full text
    Additional file 1: Table S1. Instrumental variables used in MR analysis of the association between gut microbiota and PE. Table S2. Full result of MR estimates for the association between gut microbiota and PE. Table S3. The heterogeneity of gut microbiota instrumental variables. Table S4. Directional horizontal pleiotropy assessed by intercept term in MR Egger regression of the association between gut microbiota and PE. Table S5. MR-PRESSO analysis for the association between gut microbiota and PE. Table S6. Instrumental variables used in the MR analysis of the association between PE and gut microbiota. Table S7. Full result of MR estimates for the association between PE and gut microbiota. Table S8. The heterogeneity of gut microbiota instrumental variables. Table S9. Directional horizontal pleiotropy assessed by intercept term in MR Egger regression of the association between PE and gut microbiota. Table S10. MR-PRESSO analysis for the association between PE and gut microbiota

    The Incidence of Postpartum Hemorrhage in Pregnant Women with Placenta Previa: A Systematic Review and Meta-Analysis

    No full text
    <div><p>Background</p><p>The global burden of postpartum hemorrhage (PPH) in women with placenta previa is a major public health concern. Although there are different reports on the incidence of PPH in different countries, to date, no research has reviewed them.</p><p>Objective</p><p>The aim of this study was to calculate the average point incidence of PPH in women with placenta previa.</p><p>Methods</p><p>A systematic review and meta-analysis of observational studies estimating PPH in women with placenta previa was conducted through literature searches in four databases in Jul 2016. This study was totally conducted according to the MOOSE guidelines and in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses standard.</p><p>Results</p><p>From 1148 obtained studies, 11 included in the meta-analysis, which involved 5146 unique pregnant women with placenta previa. The overall pooled incidence of PPH was 22.3% (95% CI 15.8–28.7%). In the subgroup, the prevalence was 27.4% in placenta previas, and was 14.5% in low-lying placenta previa; the highest prevalence was estimated in Northern America (26.3%, 95%CI 11.0–41.6%), followed by the Asia (20.7%, 95%CI 12.8–28.6%), Australia (19.2%, 95% CI 17.2–21.1%) and Europe (17.8%, 95% CI, 11.5%-24.0%).</p><p>Conclusions</p><p>The summary estimate of the incidence of PPH among women with placenta previa was considerable in this systematic review. The results will be crucial in prevention, treatment, and identification of PPH among pregnant women with placenta previa and will be contributed to the planning and implantation of relevant public health strategies.</p></div
    corecore